格隆汇10月15日丨中国平安(02318.HK)宣布，公司已收到国家金融监督管理总局核准洪小源、宋献中和 陈晓峰任职公司董事之资格之批复。据此，洪小源、宋献中和陈晓峰担任公司第十三届董事会独立非执 行董事的委任于2025年10月15日起生效。 ...

馬明哲 （董事長） 謝永林 （總經理、聯席首席執行官） 郭曉濤 （聯席首席執行官、副總經理） 付欣 （副總經理、首席財務官） 蔡方方 （副總經理） 非執行董事 謝吉人 楊小平 何建鋒 蔡潯 董事名單與其角色和職能 中國平安保險（集團）股份有限公司第十三屆董事會（「董事會」）成員與其角色和職能載列 如下： 執行董事 1 | | 委員會 | 提名薪酬委員會 | 審計與風險管理 | 關聯交易控制與消費 | 戰略與投資決策 | | --- | --- | --- | --- | --- | --- | | | | | 委員會 | 者權益保護委員會 | 委員會 | | 董事 | | | | | | | 馬明哲 | | | | | C | | 謝永林 | | | | | | | 郭曉濤 | | | | | | | 付欣 | | | | | | | 蔡方方 | | | | M | | | 謝吉人 | | | | | | | 楊小平 | | | M | | M | | 何建鋒 | | | | | M | | 蔡潯 | | | | | | | 吳港平 | | M | C | M | | | 金李 | | C | | M | M ...

Core Insights - The Chinese innovative drug sector is experiencing significant opportunities, with a surge in business development (BD) transactions and supportive policies for commercial health insurance [1][2] Group 1: Business Development Transactions - The total amount of external licensing transactions for innovative drugs in China is expected to reach nearly $66 billion in the first half of 2025, surpassing the total of $51.9 billion for the entire year of 2024, indicating BD's role as a major growth accelerator for the industry [1] - The current period is characterized as a "harvest season" for BD transactions in the innovative drug sector [1] Group 2: Policy Support for Innovative Drugs - The National Financial Regulatory Administration released guidelines on September 30 to promote high-quality development of health insurance, emphasizing flexible and effective payment support for innovative drugs and devices [1] - The establishment of a commercial insurance innovative drug directory, led by the National Medical Insurance Administration, aims to create a "second channel" for innovative drug payments, with the first version of expert review results already published [1] Group 3: Challenges in Payment Systems - Experts highlight that the diversification of drug payment solutions, while alleviating economic burdens on patients, has introduced challenges such as inconsistent application processes and settlement cycles across different payment channels [1] - Traditional commercial insurance claims processes are complicated, with issues like excessive documentation, long waiting periods, and significant upfront payment pressures on patients [1] Group 4: Innovations in Payment Solutions - The industry is accelerating innovation, with a focus on one-stop settlement solutions for medical insurance and commercial insurance [2] - Ping An Group has developed "Ping An Medical Health Payment," the first product in China utilizing medical insurance data for seamless claims processing, eliminating the need for patients to make upfront payments [2] - The "One Code Direct Payment" platform by Meixin Health expands the direct payment network to major hospitals nationwide, integrating various payment methods into a single interface, significantly simplifying the payment process for patients [2] Group 5: Systematic Development of Payment Framework - The trend of policy guidance and platform integration signifies a new phase in the construction of the innovative drug payment system, transitioning from mere policy guidance to systematic and institutional development [3] - Third-party management platforms, already a mature model in international commercial health insurance, are expected to provide standardized services in areas such as eligibility verification, medication management, payment settlement, compliance tracking, cost control, and fraud prevention [3]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責 , 對其 準確性或完整性亦不發表任何聲明 , 並明確表示 , 概不對因本公告全部或任何部份內容而 產生或因倚賴該等內容而引致的任何損失承擔任何責任。 自 2025 年 10 月 15 日起，本公司第十三屆董事會各專業委員會人員組成亦將同步調整。 有關進一步詳情，請參見本公司日期為 2025 年 10 月 15 日有關董事名單與其角色和職 能的公告。 公告 委任獨立非執行董事 謹此提述中國平安保險（集團）股份有限公司（「本公司」）日期為 2025年 3月 19日 及 2025 年 5 月 13 日之公告（「該等公告」）及本公司日期為 2025 年 4 月 17 日之通函 （「通函」），內容有關（其中包括）建議委任獨立非執行董事以及於 2025 年 5 月 13 日召開的股東週年大會選舉洪小源先生（「洪先生」）、宋獻中先生（「宋先生」） 和陳曉峰先生（「陳先生」）為本公司第十三屆董事會（「董事會」）獨立非執行董 事。洪先生、宋先生和陳先生的委任須待獲得國家金融監督管理總局核准彼等董事任 職資格後方會生效。除文義另有指定者外，本公告中所用詞彙與 ...

Core Insights - PAObank, a digital bank under Ping An Group, has successfully launched an "Anti-Fraud Strategy Platform" in collaboration with OneConnect, marking a significant advancement in AI technology application within Hong Kong's banking sector [1][2] - The platform aims to combat deepfake fraud risks by utilizing AI to enhance fraud detection and risk management capabilities in the banking industry [1][3] Group 1: AI Technology and Fraud Prevention - The "Anti-Fraud Strategy Platform" is part of the GenA.I. sandbox launched by the Hong Kong Monetary Authority, focusing on risk management and fraud prevention in the banking sector [1][2] - The platform employs advanced AI facial recognition technology to verify user identities in real-time, helping to detect potential fraudulent activities [2][3] - The platform has a detection defense rate exceeding 99%, showcasing its effectiveness in identifying complex attacks such as face-swapping and forged videos [3] Group 2: Business Performance and Growth - As of Q3 2025, PAObank's total customer deposits have surpassed 8 billion HKD, indicating strong growth in personal banking services [2] - Ping An Group has developed a comprehensive database with over 3.2 trillion text data, 310,000 hours of annotated voice data, and over 7.5 billion image data, enhancing its AI capabilities across various business scenarios [4] - The implementation of AI has led to significant operational efficiencies, including a 94% instant underwriting rate for life insurance policies and a 64.4 billion CNY reduction in claims fraud for property insurance [4]

该行预计中国平安第三季除税后经营溢利同比升8.1%，在相同基准下，今年首九个月的增长率将升至 5%。另外，由于股票市场利好及较高配置，第三季净盈利同比增长或达31%，带动今年首九个月同比 增长6%。另外，大摩预期会有较高的FYP增长，而利润率亦会适度改善，令第三季的新业务价值增长 45%，今年首九个月增长将升至42%。 摩根士丹利发布研报称，整体而言，预期中国平安（601318）(02318)第三季业绩稳健，尤其是新业务 价值和除税后经营溢利持续改善，以及净盈利因人寿业务高增长而表现强劲。该行予中国平安"增持"评 级，目标价70港元。 ...

摩根士丹利发布研报称，整体而言，预期中国平安(02318)第三季业绩稳健，尤其是新业务价值和除税 后经营溢利持续改善，以及净盈利因人寿业务高增长而表现强劲。该行予中国平安"增持"评级，目标价 70港元。 该行预计中国平安第三季除税后经营溢利同比升8.1%，在相同基准下，今年首九个月的增长率将升至 5%。另外，由于股票市场利好及较高配置，第三季净盈利同比增长或达31%，带动今年首九个月同比 增长6%。另外，大摩预期会有较高的FYP增长，而利润率亦会适度改善，令第三季的新业务价值增长 45%，今年首九个月增长将升至42%。 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [4][6] Core Viewpoints - The report highlights the release of the "Guiding Opinions on Promoting the High-Quality Development of Health Insurance" by the National Financial Regulatory Administration, which includes six key points aimed at developing commercial medical insurance, nursing insurance, disability insurance, and disease insurance, promoting the integration of health insurance and health management, and facilitating the coordinated development of the health industry [4][5] - The support for insurance companies with good regulatory ratings to develop participating long-term health insurance is expected to significantly impact listed insurance companies [5][6] - The report anticipates that the actual payment costs for participating disease insurance may decrease, opening up innovation opportunities for insurance products [6] Summary by Sections Industry Performance - The growth rate of health insurance premiums has declined from a peak of 40%-70% between 2014-2016 to below 10% since 2021, indicating a challenging sales environment for new long-term disease insurance policies [5] - The proportion of high-value critical illness insurance has decreased from 64% in 2020 to 56.4% in 2023 [5][11] Sales Trends - The sales of long-term disease insurance have weakened due to previous extensive coverage and a reduction in the preset interest rate from 3.5% to 2%, leading to higher policy prices [5][6] - Future sales growth may come from new births or previously uncovered populations, as well as existing policyholders increasing their coverage after price adjustments [5][6] Product Innovation - The report expects further guidelines on the development of participating disease insurance products, allowing insurance companies to innovate and meet specific customer needs [6] - The current environment for insurance industry spreads is improving, supporting the overall positive outlook for the industry [6][7]

Core Insights - PAO Bank Limited and OneConnect Financial Technology have been selected for the second cohort of the HKMA's Generative AI Sandbox to develop an "Anti-Fraud Strategy Platform" that utilizes advanced AI for deepfake fraud detection [1][2] - The platform aims to enhance risk management and customer protection by employing AI-powered facial recognition to verify user identities in real time [1][2] - Ping An Group has established itself as a leader in AI development, serving approximately 247 million individual customers and over 4 million corporate clients, with significant data resources to support AI-driven innovations [3][4] Company Developments - PAObank is leveraging technological solutions from Ping An and OneConnect to enhance operational efficiency and productivity, focusing on combating deepfake fraud [2][5] - OneConnect's anti-fraud solution integrates over 25 digital modules, achieving a 99% success rate in defending against deepfake threats and serving 214 enterprises across 21 countries by mid-2025 [4][6] Technological Advancements - By June 2025, Ping An had amassed over 3.2 trillion textual data points and deployed large AI models in over 650 business scenarios, resulting in 818 million usage calls that improved service efficiency and risk mitigation [3][4] - The AI capabilities of OneConnect include advanced facial recognition and deepfake detection, which are fully aligned with the HKMA's e-banking security framework [4][5] Strategic Vision - Ping An is committed to a dual-driver strategy of "integrated finance + health and senior care," focusing on digital transformation through innovation [5][7] - PAObank aims to enhance AI applications in risk management and product development to provide a secure banking experience as a leading digital bank [5][9]

Core Insights - The insurance sector experienced a 2.0% increase on October 15, with Xinhua Insurance leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Insurance Sector Performance - Xinhua Insurance (601336) closed at 67.87, with a rise of 3.62% and a trading volume of 443,600 shares [1] - China Pacific Insurance (601601) closed at 36.90, up 2.50%, with a trading volume of 620,100 shares [1] - Ping An Insurance (601318) closed at 57.81, increasing by 2.35%, with a trading volume of 837,000 shares [1] - China Life Insurance (601628) closed at 40.70, up 1.80%, with a trading volume of 193,500 shares [1] - China Reinsurance (601319) closed at 8.22, with a slight increase of 0.61% and a trading volume of 1,016,700 shares [1] Capital Flow Analysis - The insurance sector saw a net inflow of 1.014 billion yuan from institutional investors, while retail investors experienced a net outflow of 660 million yuan [1] - Major capital inflows and outflows for specific companies include: - Ping An Insurance: 6.46 billion yuan net inflow from institutional investors, with a 13.49% share [2] - China Pacific Insurance: 213 million yuan net inflow from institutional investors, with a 9.41% share [2] - Xinhua Insurance: 127 million yuan net inflow from institutional investors, with a 4.27% share [2] - China Life Insurance: 28.87 million yuan net inflow from institutional investors, with a 3.69% share [2] - China Reinsurance: 708,600 yuan net outflow from institutional investors, with a -0.09% share [2]